Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
TNF superfamily member 8 (TNFSF8), also known as CD30 ligand (CD30L), is a type II transmembrane TNF-family ligand encoded by the TNFSF8 gene and expressed on activated immune-cell surfaces. Its N-terminal cytoplasmic region and single transmembrane helix anchor a C-terminal extracellular TNF homology domain that supports homotrimer formation and recognition of TNFRSF8/CD30. Proteolytic processing can release a soluble TNFSF8 form, but the membrane-bound ligand is a principal signaling form. Binding to TNFRSF8 on neighboring cells promotes receptor clustering and downstream signaling. Changes in TNFSF8 surface abundance or shedding can therefore alter receptor-dependent immune responses across lymphoid compartments.
Sequence variants within TNFSF8 coding regions might disrupt trimer assembly or receptor binding capacity. TNFSF8 can exist as both membrane-bound and soluble ligand forms. Its type II transmembrane topology supports direct cell-cell ligand presentation, while soluble TNFSF8 generated by proteolytic processing can contribute to extracellular signaling. Altered TNFSF8 expression or shedding may shift tissue immune responses, making this ligand a suitable immunology research target.
Fig. 1 Conserved structural and activation paradigm of TNF‑superfamily ligand‑receptor pairs. Ligands assemble as homotrimers; receptors adopt quiescent oligomeric arrangement at cell membrane. Ligand engagement induces receptor conformational rearrangement and recruitment of cytoplasmic adaptor molecules to initiate downstream signalling.1
The biological functions of TNFSF8 are focused on membrane-associated homotrimer assembly, TNFRSF8/CD30 engagement, and signaling by membrane-bound or soluble ligand forms:
Creative Biolabs offers TNFSF8 membrane protein samples produced under unified preparation workflows, including full-length TNFSF8 constructs and isolated extracellular TNF homology-domain variants. Full-length forms retain the transmembrane segment and suit membrane-ligand research, while soluble ectodomain variants can support receptor-binding studies. All batches receive uniform quality screening. Functional assessments may be performed under simulated membrane or extracellular conditions. TNF-fold structural features are preserved across batches for comparative receptor-binding testing. Full-length TNFSF8 samples retain intact trimerization and receptor-contact surfaces after preparation, supporting comparative analysis of ligand-receptor interactions.
Not finding the membrane Protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides cell research models with adjustable TNFSF8 expression levels, suitable for structural observation of membrane TNF ligands and immune ligand-receptor interaction research. Sample assessment covers cell-surface target detection and preliminary receptor-binding analysis, enabling side-by-side comparison of ligand activity under varying expression abundances. These cell models can be paired with immune signal detection schemes to track response shifts linked to TNFSF8 surface expression and soluble-ligand release.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-TNFSF8 recombinant antibodies are generated via standardized protein preparation workflows, compatible with cell-surface or soluble ligand detection and homotrimer complex identification. The antibody series supports multi-dimensional observation of TNFSF8 distribution within lymphoid tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for TNFSF8 research:
TNFSF8 is primarily a type II transmembrane TNF ligand that forms homotrimers and binds TNFRSF8/CD30; a soluble form can also arise through proteolytic processing.
TNFSF8 surface expression and soluble-ligand release might modulate tissue immune responsiveness, serving as a key mediator of lymphoid homeostasis biological processes.
No, all TNFSF8 related products and services are strictly for research use only, and cannot be applied in clinical workflows. All material design and functional screening are optimized exclusively for basic laboratory research, without meeting clinical application criteria.
Offerings include full-length TNFSF8 membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on TNF ligand-receptor interactions.
Laboratory analysis schemes may include receptor co-binding assays to assess ligand recognition capacity under simulated membrane or extracellular environments.
